3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with interleukin-8 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YS; Huang, LJ; Kuo, SC; Tsai, CR; Wang, JP | 1 |
| Chen, S; Cohen-Sola, KA; Goydos, JS; Jeong, BS; Koo, J; Li, J; Lin, Y; Mehnert, JM; Shin, SS; Wen, Y | 1 |
2 other study(ies) available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and interleukin-8
| Article | Year |
|---|---|
The blockade of cyclopiazonic acid-induced store-operated Ca2+ entry pathway by YC-1 in neutrophils.
Topics: Actins; Adenosine Triphosphate; Amidines; Animals; Aristolochic Acids; Barium; Benzylamines; Calcium; Calcium Signaling; Calcium-Transporting ATPases; Drug Interactions; Enzyme Inhibitors; Indazoles; Indoles; Interleukin-8; Membrane Potentials; Mitochondria; Neutrophils; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sodium; Sphingosine | 2004 |
Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Topics: Angiogenesis Inhibitors; Animals; Cell Movement; Heterocyclic Compounds, 3-Ring; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Inhibitor of Apoptosis Proteins; Interleukin-8; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, Metabotropic Glutamate; Riluzole; Signal Transduction; Sirolimus; Skin Neoplasms; Survivin; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |